1-25563697-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015627.3(LDLRAP1):​c.653C>T​(p.Thr218Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00149 in 1,613,904 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T218M) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0076 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00086 ( 18 hom. )

Consequence

LDLRAP1
NM_015627.3 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:7

Conservation

PhyloP100: 0.336

Publications

6 publications found
Variant links:
Genes affected
LDLRAP1 (HGNC:18640): (low density lipoprotein receptor adaptor protein 1) The protein encoded by this gene is a cytosolic protein which contains a phosphotyrosine binding (PTD) domain. The PTD domain has been found to interact with the cytoplasmic tail of the LDL receptor. Mutations in this gene lead to LDL receptor malfunction and cause the disorder autosomal recessive hypercholesterolaemia. [provided by RefSeq, Jul 2008]
LDLRAP1 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025242567).
BP6
Variant 1-25563697-C-T is Benign according to our data. Variant chr1-25563697-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 520395.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00758 (1154/152338) while in subpopulation AFR AF = 0.026 (1079/41574). AF 95% confidence interval is 0.0247. There are 12 homozygotes in GnomAd4. There are 490 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDLRAP1NM_015627.3 linkc.653C>T p.Thr218Ile missense_variant Exon 7 of 9 ENST00000374338.5 NP_056442.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDLRAP1ENST00000374338.5 linkc.653C>T p.Thr218Ile missense_variant Exon 7 of 9 1 NM_015627.3 ENSP00000363458.4

Frequencies

GnomAD3 genomes
AF:
0.00754
AC:
1147
AN:
152220
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0259
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00217
AC:
545
AN:
250890
AF XY:
0.00155
show subpopulations
Gnomad AFR exome
AF:
0.0283
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000468
Gnomad NFE exome
AF:
0.000238
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000859
AC:
1256
AN:
1461566
Hom.:
18
Cov.:
31
AF XY:
0.000737
AC XY:
536
AN XY:
727086
show subpopulations
African (AFR)
AF:
0.0289
AC:
969
AN:
33476
American (AMR)
AF:
0.00157
AC:
70
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000185
AC:
16
AN:
86258
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53126
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000755
AC:
84
AN:
1111986
Other (OTH)
AF:
0.00180
AC:
109
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
78
155
233
310
388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00758
AC:
1154
AN:
152338
Hom.:
12
Cov.:
32
AF XY:
0.00658
AC XY:
490
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0260
AC:
1079
AN:
41574
American (AMR)
AF:
0.00359
AC:
55
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68032
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00300
Hom.:
6
Bravo
AF:
0.00914
ESP6500AA
AF:
0.0220
AC:
97
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00271
AC:
329
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 4 Pathogenic:1Uncertain:1Benign:3
Jun 28, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 19, 2019
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

NM_015627.2:c.653C>T in the LDLRAP1 gene has an allele frequency of 0.028 in African subpopulation in the gnomAD database, including 13 homozygous occurrences. It was detected in one individual with autosomal recessive hypercholesterolemia, compound heterozygous with c.863C>T (p.Ser288Leu) (PMID: 29245109). Benign computational verdict because benign predictions from DANN, DEOGEN2, EIGEN, FATHMM-MKL, MutationTaster, PrimateAI, REVEL and SIFT. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, BP4, PM3. -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:3
Oct 08, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2020
H3Africa Consortium
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.08, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hypercholesterolemia Benign:1
Jan 16, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
8.4
DANN
Benign
0.91
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.62
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.34
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.034
Sift
Benign
0.40
T
Sift4G
Benign
0.45
T
Polyphen
0.045
B
Vest4
0.13
MVP
0.53
MPC
0.21
ClinPred
0.0044
T
GERP RS
0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.047
gMVP
0.072
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114583297; hg19: chr1-25890188; API